Literature DB >> 33966250

IGF-1R Transported to the Cell Nuclei to Regulate the Proliferation of Breast Cancer Cells.

Baoliang Guo1, Zheng Lv2, Chunguo Cui3, Wan Wang4.   

Abstract

Under normal physiological conditions, IGF-1 (insulin-like growth factor-1) has important biological effects. However, many studies have found that IGF-1 is closely related to the occurrence and development of breast cancer. But up to now, the cellular properties of IGF-1 have not been systematically explored in breast cancer cell. It is well-known that the cellular properties and behaviors of IGF-1/IGF-1R are closely related to its biological functions. In the current study, we used the breast cancer cell line as a model to explore the biological characteristics of IGF-1/IGF-1R, and found that IGF-1/IGF-1R can be internalized into the cytoplasm. In addition, we also found that IGF-1R can also enter cell nuclei under the mediation of IGF-1. Further research found that the nuclear-localized IGF-1R has important potential biological effects, which is closely associated to the proliferation of breast cancer cell, this may be achieved by regulating IGF-1R-mediated intracellular signaling. The current research has laid the foundation for investigating the relationship between IGF-1/IGF-1R system and the occurrence and development of breast cancer.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Breast cancer cells; IGF-1; IGF-1R; Nuclear localization

Mesh:

Year:  2021        PMID: 33966250     DOI: 10.1007/s12013-021-00989-8

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  2 in total

1.  Worse prognosis of osteosarcoma patients expressing IGF-1 on a tissue microarray.

Authors:  Thorsten Jentzsch; Bernhard Robl; Maren Husmann; Beata Bode-Lesniewska; Bruno Fuchs
Journal:  Anticancer Res       Date:  2014-08       Impact factor: 2.480

Review 2.  The role of IGF-1 in obesity, cardiovascular disease, and cancer.

Authors:  Nazanin AsghariHanjani; Mohammadreza Vafa
Journal:  Med J Islam Repub Iran       Date:  2019-06-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.